NeoGenomics Inc. (NEO) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
9490 NEOGENOMICS WAY FORT MYERS, FL 33912 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8734 - Testing Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 367,012 | 342,488 | 263,180 | 515,390 | 296,259 | 173,016 | |||
| Cash and cash equivalent | 367,012 | 342,488 | 263,180 | 316,827 | 228,713 | 173,016 | |||
| Short-term investments | 198,563 | 67,546 | |||||||
| Receivables | 150,540 | 131,227 | 119,711 | 112,130 | 106,843 | 94,242 | |||
| Inventory, net of allowances, customer advances and progress billings | 26,748 | 24,156 | 24,277 | 23,395 | 29,526 | 14,405 | |||
| Inventory | 26,748 | 24,156 | 24,277 | 23,395 | 29,526 | 14,405 | |||
| Prepaid expense | 20,165 | 17,987 | 15,237 | 12,354 | 11,547 | 6,327 | |||
| Contract with customer, asset, after allowance for credit loss | 100 | ||||||||
| Capitalized contract cost | 206 | ||||||||
| Asset, held-for-sale, not part of disposal group | 10,050 | ||||||||
| Other current assets | 11,722 | 8,239 | 8,077 | 8,189 | 4,555 | 2,748 | |||
| Other undisclosed current assets | 19,526 | 72,715 | 174,809 | ||||||
| Total current assets: | 596,019 | 596,812 | 605,291 | 681,508 | 448,730 | 290,738 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 79,583 | 91,769 | 96,109 | 102,197 | 45,786 | 26,492 | |||
| Property, plant and equipment | 94,103 | 92,012 | 102,499 | 109,465 | 85,873 | 64,188 | |||
| Intangible assets, net (including goodwill) | 862,447 | 895,894 | 931,026 | 969,440 | 331,736 | 325,241 | |||
| Goodwill | 522,766 | 522,766 | 522,766 | 527,115 | 211,083 | 198,601 | |||
| Intangible assets, net (excluding goodwill) | 339,681 | 373,128 | 408,260 | 442,325 | 120,653 | 126,640 | |||
| Contract with customer, asset, after allowance for credit loss | 290 | ||||||||
| Capitalized contract cost, net | 970 | ||||||||
| Restricted cash and investments | 21,919 | ||||||||
| Other noncurrent assets | 5,886 | 4,742 | 5,109 | 7,168 | 4,503 | 2,847 | |||
| Other undisclosed noncurrent assets | 48,524 | ||||||||
| Total noncurrent assets: | 1,042,019 | 1,084,417 | 1,134,743 | 1,188,270 | 539,601 | 418,768 | |||
| TOTAL ASSETS: | 1,638,038 | 1,681,229 | 1,740,034 | 1,869,778 | 988,331 | 709,506 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 84,050 | 73,495 | 60,651 | 56,225 | 49,692 | 40,933 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 38,304 | 24,727 | 21,365 | ||
| Accounts payable | 21,607 | 20,334 | 20,510 | 17,921 | 24,965 | 19,568 | |||
| Accrued liabilities | 62,443 | 53,161 | 40,141 | ||||||
| Deferred revenue | 409 | 2,130 | 7,557 | 5,192 | 4,029 | 1,610 | |||
| Debt | 200,777 | 70 | 1,135 | 2,841 | 10,432 | ||||
| Restructuring reserve | 1,519 | ||||||||
| Disposal group, including discontinued operation | |||||||||
| Other undisclosed current liabilities | 16,005 | 20,679 | 20,135 | 24,680 | 16,621 | 10,929 | |||
| Total current liabilities: | 301,241 | 96,304 | 89,932 | 87,232 | 73,183 | 63,904 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 538,198 | 535,322 | 532,554 | 169,087 | 95,028 | ||||
| Long-term debt, excluding current maturities | 538,198 | 535,322 | 532,483 | 168,120 | 91,829 | ||||
| Finance lease, liability | 71 | 967 | |||||||
| Other undisclosed long-term debt and lease obligation | (72,289) | (42,296) | (20,835) | ||||||
| Liabilities, other than long-term debt | 94,123 | 105,190 | 116,757 | 70,343 | 10,183 | 20,303 | |||
| Deferred revenue | 917 | 712 | 1,171 | ||||||
| Deferred income tax liabilities | 21,510 | 24,285 | 34,750 | 55,475 | 5,415 | 15,566 | |||
| Other liabilities | 11,772 | 13,034 | 13,055 | 13,951 | 4,056 | 3,566 | |||
| Operating lease, liability | 60,841 | 67,871 | 68,952 | 72,289 | 42,296 | 24,034 | |||
| Other undisclosed noncurrent liabilities | 340,335 | 71,372 | 41,584 | 22,863 | |||||
| Total noncurrent liabilities: | 434,458 | 643,388 | 652,079 | 674,269 | 220,854 | 138,194 | |||
| Total liabilities: | 735,699 | 739,692 | 742,011 | 761,501 | 294,037 | 202,098 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 902,339 | 941,537 | 998,023 | 1,108,277 | 694,294 | 507,408 | |||
| Additional paid in capital | 1,228,198 | 1,190,139 | 1,160,882 | 1,123,628 | 701,357 | 520,278 | |||
| Accumulated other comprehensive income (loss) | (206) | (1,674) | (3,899) | (638) | 10 | (1,618) | |||
| Accumulated deficit | (325,781) | (247,055) | (159,087) | (14,837) | (7,185) | (11,357) | |||
| Other undisclosed equity, attributable to parent | 128 | 127 | 127 | 124 | 112 | 105 | |||
| Total equity: | 902,339 | 941,537 | 998,023 | 1,108,277 | 694,294 | 507,408 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,638,038 | 1,681,229 | 1,740,034 | 1,869,778 | 988,331 | 709,506 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 660,566 | 591,643 | 509,728 | 484,329 | 444,448 | 408,830 | ||
| Cost of revenue (Cost of Product and Service Sold) | (370,466) | (347,039) | (321,832) | (297,269) | (258,555) | (211,994) | ||
| Gross profit: | 290,100 | 244,604 | 187,896 | 187,060 | 185,893 | 196,836 | ||
| Operating expenses | (382,206) | (352,340) | (345,519) | (305,814) | (199,885) | (183,830) | ||
| Operating income (loss): | (92,106) | (107,736) | (157,623) | (118,754) | (13,992) | 13,006 | ||
| Nonoperating income (expense) | 18,048 | 644 | (213) | (499) | 11,861 | (4,630) | ||
| Investment income, nonoperating | 18,427 | |||||||
| Other nonoperating income (expense) | (379) | 644 | (213) | (499) | 11,861 | (4,630) | ||
| Interest and debt expense | (6,617) | (6,907) | (1,506) | (5,082) | (8,419) | (4,731) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (80,675) | (113,999) | (159,342) | (124,335) | (10,550) | 3,645 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 16,902 | 109,260 | (3,506) | |||||
| Income (loss) from continuing operations before income taxes: | (80,675) | (97,097) | (159,342) | (15,075) | (14,056) | 3,645 | ||
| Income tax benefit | 1,949 | 9,129 | 15,092 | 6,728 | 18,228 | 4,361 | ||
| Income (loss) from continuing operations: | (78,726) | (87,968) | (144,250) | (8,347) | 4,172 | 8,006 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (8,347) | 4,172 | 8,006 | |
| Net income (loss) available to common stockholders, diluted: | (78,726) | (87,968) | (144,250) | (8,347) | 4,172 | 8,006 | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (78,726) | (87,968) | (144,250) | (8,347) | 4,172 | 8,006 | ||
| Other undisclosed comprehensive income | ||||||||
| Comprehensive income (loss): | (78,726) | (87,968) | (144,250) | (8,347) | 4,172 | 8,006 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 1,468 | 2,225 | (3,261) | (648) | 1,628 | (1,039) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (77,258) | (85,743) | (147,511) | (8,995) | 5,800 | 6,967 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.